activation is highly sensitive to Cln3 level, it is well suited as a sensor of cell growth.
Despite the requirement for Cln3 for timely activation of G1-specific genes, it is not absolutely required for expression of those genes or for cell viability. However, it becomes essential in the absence of CLN1 and CLN2 ( This has led to the suggestion that one or more regulatory factors intervene between the G1 cyclin/CDK and the G1-specific transcription factors. A similar system has been well established in metazoans, in which the tumor suppressor Rb represses E2F-dependent transcription during G1 phase but is then inactivated via phosphorylation by cyclin D/Cdk4, leading to the activation of genes required for entry into S phase (reviewed by Dyson [1998] and Nevins [2001] ). In fact, that mammalian regulatory cascade has been reconstructed at least in part in yeast cells (Hatakeyama et al., 1994) .
In the interest of identifying putative targets of the Cln3/CDK, we have isolated and characterized components of the SBF transcription factor complex. Among the proteins forming a complex with SBF was Whi5, identified in genomic screens for mutants that result in an abnormally small cell size (Jorgensen et al., 2002; Zhang et al., 2002) . We show here that Whi5 associates with the promoter bound SBF transcription factor to repress transcription. Furthermore, Cln3 antagonizes binding of Whi5 to SBF-responsive promoters and its activity as a transcriptional repressor. We suggest that Whi5, like Rb, represses G1-specific transcription during chronous cultures were probed with anti-myc to detect Whi5-(C) Whi5 interacts with SBF. Extracts were prepared from wild-type 13xmyc or with anti-HA to detect Mbp1-3xHA. or swi6⌬ strains carrying WHI5-TAP together with SWI4-6xmyc. Anti-(E) Whi5 associates specifically with Swi6 and Swi4. The number of TAP (IgG-IP) and anti-myc (␣myc-IP) immune complexes from asynspectra representing known SBF and MBF components obtained chronous cultures were probed with ␣PAP to detect Whi5-TAP or from the MudPIT analysis of Whi5-TAP was normalized to Swi6 with anti-myc to detect Swi4-6xmyc.
(based upon both spectra number and protein size).
Results

Identification of Components of SBF and MBF
To identify potential targets of Cln3/CDK required for activation of G1-specific transcription, we sought to define components of the SBF and MBF transcription factors from cells that were either arrested in G1 phase prior to transcriptional activation or released into late G1 phase, during which G1-specific transcription is maximally activated. To achieve this, Swi4, Swi6, and Mbp1, the known components of the G1-specific transcription factors, were tagged at the carboxyterminus with the tandem affinity purification (TAP) epitope at their genomic loci in a cln1⌬ cln2⌬ strain carrying CLN3 under control of the GAL1 promoter as its only source of G1 cyclin. Cells expressing each of the epitope-tagged transcription factor subunits were either arrested during G1 phase by depletion of Cln3 on raffinose or released from G1 phase arrest for 20 min (the predetermined interval required for maximal transcriptional activation) by addition of galactose and protein complexes purified by TAP (Rigaut et al., 1999) . Silver-stained SDS-PAGE of the TAP-purified fractions shows that each contains, in addition to the epitope-tagged component, the expected SBF or MBF components plus additional unknown copurified proteins ( Figure 1A) . Identification of the components of the transcription factor complexes was accomplished using the mass spectrometry-based multidimensional protein interaction technology (MudPIT; Wolters et al., 2001), resulting in the identification of each of the expected SBF and MBF components (Swi6, Swi4, and/or Mbp1; Figure 1B ) along with several components that, to our knowledge, are novel. Those components were classified as SBF specific (Swi4 and Swi6 fractions), MBF specific (Mbp1 and Swi6 fractions), Swi4 specific, or Mbp1 specific. No in the identification of both Swi6 and Swi4 with high confidence, whereas Mbp1 was not detected ( Figure  1E ). Together, these data establish that Whi5 is a compoWhi5 Is a Component of SBF To confirm the specific interaction of Whi5 with SBF nent of SBF. detected by MudPIT, we evaluated the interaction of those proteins by coimmunoprecipitation (coIP). Immune comWhi5 Inhibits SBF-Dependent G1-Specific Transcription plexes containing TAP-tagged Whi5 also contained Myc-tagged Swi6 (data not shown) and Myc-tagged WHI5 (YOR083w) was identified previously based upon the small cell size caused by a null mutation (Jorgensen Swi4 (Figure 1C ), whereas no Mbp1-HA was detected ( Figure 1D ). Accordingly, Whi5-TAP coimmunoprecipiet al., 2002). Further analysis suggested that Whi5 might act as an inhibitor of G1-specific transcription. We find tated with Swi6-6xmyc (data not shown) and Swi4-that whi5⌬ results in a dramatic reduction in cell size in both wild-type ( Figure 2A ) and mbp1⌬ mutant strains (data not shown) but does not affect the size of swi4⌬ mutants (Figure 2A) , consistent with the hypothesis that Whi5 negatively regulates SBF but not MBF. Furthermore, as expected, expression of GAL1-WHI5 results in an increase in cell size in otherwise wild-type cells (Figure 2B) but has little or no effect on swi4⌬ mutants, which are already large (data not shown). Together, these observations suggest that the inhibitory effect of Whi5 is exerted exclusively via SBF. In fact, simply integrating a second allele of WHI5 in tandem with the wildtype allele results in a significant increase in cell size (data not shown), suggesting that WHI5 acts as a dosedependent inhibitor of Start, much like CLN3 acts as a dose-dependent activator (Wijnen et al., 2002).
Cln3 Acts via Whi5 to Promote Cell Cycle Initiation
To evaluate whether Cln3 antagonizes Whi5 activity, we compared the cell size of asynchronous populations of whi5⌬ and cln3⌬ mutants to cln3⌬ whi5⌬ mutants (Figure 2C) . Inactivation of Whi5 was not only sufficient to suppress the increase in cell size caused by inactivation of Cln3 but resulted in a cell size distribution identical to that caused by whi5⌬. This epistasis relationship suggests that Cln3 acts via Whi5 to regulate cell cycle initiation.
To eliminate the potential contributions to cell size of cell cycle defects outside of G1 phase, we evaluated the critical cell size (cell volume) at which bud emergence occurs in small G1 daughter cells isolated by centrifugal elutriation. Previous analysis has shown critical cell size at budding to be directly related to the activation of G1-specific transcription and to be a sensitive assay for the G1-specific function of Cln3 (Dirick et al., 1995; Stuart and Wittenberg, 1995). Small G1 daughter cells were isolated from asynchronous populations of wild-type and whi5⌬ strains by centrifugal elutriation and allowed to progress through the cell cycle. Whereas wild-type cells budded at ‫53ف‬ fl, whi5⌬ resulted in a dramatic reduction in the cell size required for budding (Ͻ20 fl; Figure 3A , top panel). In fact, isolation of the smallest cells from the asynchronous population failed to yield greater than 80% unbudded cells, many of which budded within the first 20 min of growth. We conclude that the whi5⌬ mutation results in a dramatic advancement of Start and that a large fraction of the small G1 daughter cells in the whi5⌬ population have already executed Start prior to abscission from the mother cell.
To more precisely establish the relationship between a comparable size to whi5⌬ mutants (Ͻ20 fl; Figure 3A , MBP1 ( Figure 3C ). While bck2⌬ cln3⌬ whi5⌬ mbp1⌬ mutants are able to proliferate in the absence of top panel). As with whi5⌬ mutants, it is difficult to isolate a pure unbudded population. Both of these observations YEpURA3-CLN3, bck2⌬ cln3⌬ whi5⌬ swi4⌬ mutants are not. Thus, bypass of the lethality of bck2⌬ cln3⌬ mutants demonstrate that whi5⌬ is epistatic to cln3⌬, suggesting a pathway in which Cln3 exerts its positive effect on depends upon the activity of SBF. Consistent with this finding, the level of CLN2 gene expression in an asyncell cycle initiation by antagonizing the negative effect of Whi5. chronous population of bck2⌬ cln3⌬ whi5⌬ mutants is comparable to that observed in wild-type cells, whereas expression is negligible in a bck2⌬ cln3⌬ (GAL1-CLN3) Whi5 Represses G1-Specific Transcriptional strain grown on glucose (data not shown). In contrast, Activation Upstream of SBF we find that inactivation of WHI5 is insufficient to support The early initiation of budding, as observed in whi5⌬ the viability of either bck2⌬ swi6⌬ GAL1-CLN2 or cln1⌬ mutants, often reflects premature activation of G1-specln2⌬ cln3⌬ GAL1-CLN3 strains in the presence of glucific transcription. To evaluate SBF-dependent transcripcose (data not shown). These data provide additional tion, we measured the level of transcripts from CLN2, support for the SBF-specific role of Whi5 and, more a well-characterized SBF-dependent gene ( Figure 3A, importantly, show that inactivation of WHI5 abolishes bottom panel). The level of the CLN2 transcript in wildthe requirement for the G1-specific transcriptional actitype cells peaks at 35 fl, corresponding with bud emervators CLN3 and BCK2. gence, and is subsequently rapidly lost, presumably due to transcriptional inactivation associated with cell cycle progression (Amon et al., 1993). In contrast, the CLN2 Whi5 Binds via SBF to Promoters transcript is high in the smallest whi5⌬ mutant cells of Transcriptionally Inactive G1-Specific Genes and, as observed in wild-type cells, rapidly decreases
The identification of Whi5 as an SBF bound inhibitor as budding increases to the maximum level. We believe of transcriptional activation suggests that it may act this unexpected behavior to be a consequence of our directly at the level of SBF-dependent promoters. Bindfailure to isolate a whi5⌬ population in which the majority ing of epitope-tagged Swi4, Swi6, and Whi5 to two G1-of cells are pre-Start and, therefore, undergoing transpecific promoters, CLN2 (SBF specific) and CLB5 (MBF scriptional activation of G1-specific genes. Consistent specific), and the HXT3 promoter (SBF/MBF indepenwith that interpretation, the inactivation of G1-specific dent) was assessed by ChIP analysis. Like Swi4 ( et al., 1996), whereas none of those proteins binds de-CDC20 expression decreases when a second peak of tectably to the HXT3 promoter ( Figure 4A and data not accumulation of the CLN2 transcript is observed.
shown). Binding of Whi5 to the CLN2 promoter is not Consistent with its effect on the minimal cell size at observed in a swi4⌬ strain ( Figure 4B) , and, as predicted, budding, inactivation of CLN3 in wild-type cells results that binding is independent of Mbp1. We conclude that in a dramatic delay in transcriptional induction of CLN2 Whi5 binds to G1-specific promoters via SBF. (Figure 3A, bottom panel) . Analysis of the CLN2 tranTo evaluate the relationship between Whi5 binding to script in a whi5⌬ cln3⌬ double mutant revealed that, like SBF-dependent promoters and G1-specific transcripbud emergence, CLN2 expression is coincident with that tional activation, we analyzed timing of Whi5 binding to observed in the strain carrying whi5⌬ alone ( Figure 3A , the promoters of three SBF targets, CLN2, CLN1, and bottom panel).
PCL1, by ChIP analysis following release from G1 phase Together, these findings demonstrate that inactivaarrest by mating pheromone. We find that, like Swi6, tion of whi5⌬ bypasses the requirement for Cln3 for Whi5 is bound to the CLN2 promoter in mating phero-SBF-dependent transcriptional activation. We conclude mone-arrested cells. However, in contrast to Swi6, it that Whi5 delays G1-specific transcriptional activation dissociates just prior to transcriptional activation (Figure and thereby cell cycle initiation and that Cln3 antago-4C, upper panel). As indicated by Swi6 binding, SBF nizes that inhibition.
remains associated with the CLN2 promoter until cells enter the budded phase of the cell cycle and transcription is inactivated ( Figure 4C, lower panel) . A similar Inactivation of Whi5 Bypasses the Lethality of bck2⌬ cln3⌬ Mutants pattern of Whi5 binding was observed at the CLN1 and PCL1 promoters. Thus, association of Whi5 with SBFBecause inactivation of WHI5 was sufficient to bypass the requirement for CLN3 for activation of SBF-dependependent promoters early in G1 phase correlates with transcriptional repression, and its subsequent dissociadent transcription, we sought to determine whether it could also bypass the lethality resulting from bck2⌬ tion correlates with Cln3/CDK-dependent G1-specific transcriptional activation. cln3⌬ ( Figure 3C ). Whereas a bck2⌬ cln3⌬ mutant is unable to survive under conditions that select for loss We evaluated whether Cln3 was sufficient for dissociation from SBF-dependent promoters or whether addiof the YEpURA3-CLN3 plasmid, the bck2⌬ cln3⌬ whi5⌬ mutant remains viable following loss of that plasmid. To tional cyclins were required. Binding of Whi5 to the same three promoters was evaluated by chromatin immunodetermine whether SBF, MBF, or both are required for that bypass, we evaluated the requirement for SWI4 and precipitation in cells that lack CLN3, express CLN3 as their only G1 cyclin, or express no G1 cyclins. As pretranscription ( Figure 4E ). In cells lacking G1 cyclins, CLN2 expression remained repressed, and Whi5 redicted, a decrease in the binding of Whi5 to all three promoters correlated with the activation of G1-specific mained bound to the CLN2 promoter. In cells having only CLN3 (Figure 4E ), the rapid activation of CLN2 expression following release from arrest was coordinate with the dissociation of Whi5 from each of the SBFdependent promoters, as observed in wild-type cells. In contrast, cells lacking CLN3 only activated CLN2 expression after a significant delay and did so more gradually than either wild-type or cln1⌬ cln2⌬ cells. Consistent with the pattern of expression, a marked decrease in the extent and rate of dissociation of Whi5 was observed. Whereas dissociation appears rapid and concerted in the wild-type strain (Figure 4C ), the decrease is more gradual in the cln1⌬ cln2⌬ strain (Figure 4E) , suggesting a contribution of other G1 cyclins. Nevertheless, CLN1 and CLN2 are insufficient in the absence of CLN3, since Whi5 appears to remain bound in that strain until late in the time course. Together, these data strongly suggest that transcriptional activation via Cln3 is exerted via its capacity to antagonize Whi5 binding to G1-specific promoters. Figure 4F ). Whi5 was found in a complex with Swi6 even subsequent to the dissociation of both proteins from promoters. We conclude that Whi5 forms a complex with SBF independent of its binding to G1-specific promoters. Figure 4D ). Whereas Whi5-TAP migrates as a single species during early G1 phase by depletion of G1 cyclins. The Whi5-SBF complexes retained on calmodulin beads were treated with either ( Figure 4C ), a slower-migrating form of Whi5-TAP appears and becomes increasingly apparent as cells proCln-CDK complexes or Cdc28 CDK from asynchronous cells ( Figure 5D ). In both cases, Whi5-myc was phosgress into the budded phase of the cell cycle. Phosphatase treatment of Whi5-TAP demonstrates that, like the phorylated and released into the supernatant, whereas it was retained on the beads in the untreated samples. Whi5-HA protein shown in Figure 5A , even the highestmobility species is phosphorylated (data not shown).
Whereas the dissociation of Whi5 from SBF bound promoters at the time of transcriptional activation is consistent with its behavior as a transcriptional repressor of SBF-dependent genes, it does not explain the results of our MudPIT analysis that shows that Whi5 is present in a complex with SBF from cells actively transcribing CLN2. To address this issue, we analyzed Whi5 binding to Swi6 in synchronized cells by coimmunoprecipitation (
Whi5 Hyperphosphorylation Is Associated with G1-Specific Transcriptional Activation
We conclude that Cln-CDK-dependent phosphorylation is sufficient to promote dissociation of Whi5 from SBF, We conclude that Whi5 is phosphorylated at one or more positions during all cell cycle phases but that a portion consistent with the timing of its dissociation from promoters in vivo. of that protein becomes hyperphosphorylated as cells progress through G1 phase.
To establish the form of the CDK responsible for Whi5 Phosphorylation of Whi5 Determines the Timing phosphorylation, we compared the mobility of Whi5 in of SBF-Dependent Transcriptional Activation cells in which specific cyclins accumulate. Whereas all and Cell Cycle Progression three G1 cyclins accumulate in a cdc34-ts strain arrested Whi5 contains four perfect CDK consensus sites (S/Tduring late G1 phase at the restrictive temperature, a P-X-K/R; sites 1, 2, 11, and 12) and eight minimal concln1⌬ cln2⌬ cdc34-ts strain accumulates only Cln3.
sensus sequences (S/T-P; sites 3-10; Figure 6A ). Analy-B-type cyclins fail to accumulate due to the inability of sis of TAP-purified Whi5 obtained from transcriptionally cdc34 mutants to degrade the Clb/CDK inhibitor Sic1 active G1 phase cells by mass spectrometry revealed (Schwob and Nasmyth, 1993). Those strains were arthe presence of phosphopeptides representing five purested in late G1 phase by shifting to the restrictive tative CDK sites (sites 2, 4, 5, 10, and 12; data not temperature for 3 hr, and the electrophoretic mobility shown). We mutated the phosphoacceptor amino acid of Whi5 was compared to Whi5 from the same cells at those sites, along with two other sites (sites 8 and either arrested by ␣ factor to inactivate all forms of the 9), to alanine. Surprisingly, we were unable to introduce CDK or allowed to progress into G2/M phase (Figure the mutant gene (designated WHI5
7A
) under control of 5B). That analysis revealed that, whereas Cln3/CDK prothe endogenous WHI5 promoter into cells, either alone motes only a small shift in mobility, the accumulation of or in tandem with a wild-type copy of the gene. The all three G1 cyclins results in more extensive retardation, basis for that lethality has not been established. To obvisimilar to that observed at the permissive temperature ate that problem, the mutant and wild-type open reading where B-type cyclin-associated forms of the CDK accuframe were placed under control of the conditional MET3 mulate. These data suggest that Cln3/CDK promotes promoter and integrated into the genome of whi5⌬ muquantitative phosphorylation of Whi5, then leads to protant cells. As expected, both strains exhibited the small gressively greater phosphorylation by Cln1-and Cln2-cell size phenotype of the whi5⌬ mutant when grown associated CDK and then by Clb/CDK. This is consistent on methinonine-containing medium (ϩMet) to repress with the effect of Cln3 activity on Whi5 binding to G1 MET3-dependent transcription. Although cells expressspecific promoters and with the finding that dissociation ing either MET3-WHI5 or MET3-WHI5 7A became larger of Whi5 from those promoters is less concerted in the than wild-type cells after the shift to methionine-defiabsence of CLN1 and CLN2 ( Figure 4E) . cient medium (ϪMet) for several generations, the increase in cell size observed in the strain expressing WHI5 7A was substantially greater (data not shown). AnalWhi5 Phosphorylation by Cdc28 Kinase Promotes Dissociation from SBF In Vitro ysis of Whi5-myc expressed from the MET3 promoter revealed that the level of expression of both Whi5 and We evaluated whether Whi5 could act as a target for the Cdc28 CDK in vitro. TAP-tagged Cdc28 was purified Whi5 7A was comparable to that expressed from the endogenous promoter ( Figure 6B ). This suggests that the from either asynchronous cells or cells expressing only G1 cyclins (cdc34-ts mutants arrested following release effect of expression of MET3-WHI5 might result from misregulation of WHI5 expression rather than from overfrom ␣ factor arrest). Both preparations of Cdc28 CDK kinase were active against histone H1 and immunopreexpression.
To evaluate the importance of phosphorylation during cipitated 13xmyc-tagged Whi5 ( Figure 5C ). Based upon their relative kinase activity, measured using histone H1 G1 phase, cells expressing either MET3-WHI5 or MET3-WHI5 7A were pregrown in ϩMet medium and shifted as a substrate, the Cln-associated CDK appeared to be more efficient than the total CDK at phosphorylating to ϪMet medium to induce the MET3 promoter, and then small cells were isolated by centrifugal elutriation Whi5. No phosphorylation of Whi5 was observed when the immune complexes were prepared from a strain and evaluated for cell size, G1-specific gene expression, and budding ( Figure 6C ). As expected, both the timing and extent of transcriptional activation and budding observed in the MET-WHI5 strain were comparable to wildtype cells. In contrast, the MET-WHI5 7A mutant budded at a substantially larger cell size, and the expression of the SBF-dependent CLN2 transcript was delayed and reduced relative to that in cells expressing wild-type WHI5. Consistent with the specificity of Whi5 for SBF, the MBF-dependent transcript RNR1 was expressed at a comparable level to cells expressing mutant or wildtype WHI5. Finally, the lower-mobility phosphorylated forms of Whi5 observed following release from ␣ factor arrest in wild-type cells ( Figure 4D ) and cells expressing MET-WHI5-myc fail to accumulate in the MET-WHI5 7A -myc mutant (data not shown). We conclude that phosphorylation of Whi5 at one or more sites affected by the CDK site mutations is required for efficient and timely activation of SBF-dependent genes.
Discussion
We have shown that Whi5 interacts specifically with SBF but not independently with either of its known subunits or MBF. Whi5 binds to SBF at G1-specific promoters and acts as a repressor of G1-specific transcriptional activation. As cells progress into late G1 phase, Whi5 dissociates from promoters in a Cln3-dependent manner ( Figure 7A ). Dissociation is promoted by and dependent upon Cln3 in vivo and is promoted by Cln/CDK in vitro. Consistent with its behavior as an in vitro substrate for the Cdc28 CDK, mass spectrometric analysis of Whi5 demonstrates that it is phosphorylated in vivo at CDK consensus sites during late G1 phase (data not shown). Mutational analysis of a subset of the putative CDK sites in Whi5 demonstrates that Whi5 phosphorylation is required for efficient transcriptional activation of SBF-dependent genes and, consequently, for timely cell cycle initiation.
Whi5 is not simply required to keep SBF-dependent gene expression low outside of G1 phase but acts as a component of the mechanism governing periodic transcription. The pattern and extent of transcriptional activation of CLN2 in whi5⌬ and cln3⌬whi5⌬ mutants is 
